← Back to all trials
Active Not Recruiting
NCT04594772
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma
Conditions: Pancreas Cancer
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE2
Enrollment: 32
Sponsor: University of Cincinnati
Location: University of Arizona Tucson Arizona
Summary
The purpose of this study is to determine if neoadjuvant therapy to increases resection rate for pancreatic adenocarcinoma.
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of pancreatic carcinoma or adenocarcinoma confirmed by tissue. Histologies other than carcinoma or adenocarcinoma are not allowed.
* Resectable or borderline resectable primary tumor, evaluated on a baseline contrast-enhanced CT or MRI scan (CT Chest/Abdomen/Pelvis with contrast is preferred; if MRI used at baseline, then follow up with MRI as well), and defined using Intergroup criteria:
* Tumor vessel wall interface 0-360 for portal and superior mesenteric veins.
* Tumor vessel wall interface \
Source: ClinicalTrials.gov (NCT04594772). StuddyBuddy aggregates publicly available trial information.
